Gene · 6012
Papers2,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synergistic effects of hormones on structural and functional maturation of cardiomyocytes and implications for heart regeneration. | Cell Mol Life Sci | 2023 | 37541969 | PubTator, text mining | PubMed |
Feasibility of a peer-supported, WhatsApp-assisted, lifestyle modification intervention for weight reduction among adults in an urban slum of Karachi, Pakistan: a mixed-methods, single-group, pretest-post-test, quasi-experimental study. | BMJ Open | 2023 | 37527890 | PubTator, text mining | PubMed |
| Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook. | Pharmaceutics | 2023 | 37513983 | PubTator, text mining | PubMed |
| Investigating the Genetic Background of Spastic Syndrome in North American Holstein Cattle Based on Heritability, Genome-Wide Association, and Functional Genomic Analyses. | Genes (Basel) | 2023 | 37510383 | PubTator, text mining | PubMed |
| Xanthine-Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases. | Biomolecules | 2023 | 37509114 | PubTator, text mining | PubMed |
| Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies. | Curr Opin Rheumatol | 2023 | 37503636 | PubTator, text mining | PubMed |
| M1-Type Macrophages Secrete TNF-α to Stimulate Vascular Calcification by Upregulating CA1 and CA2 Expression in VSMCs. | J Inflamm Res | 2023 | 37489150 | PubTator, text mining | PubMed |
| Prevalence of anti-synthetase antibodies among systemic sclerosis patients. | Eur J Intern Med | 2023 | 37453844 | PubTator, text mining | PubMed |
| Myositis-associated interstitial lung disease. | Curr Opin Pulm Med | 2023 | 37435671 | PubTator, text mining | PubMed |
| Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE. | J Gastrointest Oncol | 2023 | 37435198 | PubTator, text mining | PubMed |
| Quantitative Proteomic Analysis of Cyanide and Mercury Detoxification by Pseudomonas pseudoalcaligenes CECT 5344. | Microbiol Spectr | 2023 | 37432117 | PubTator, text mining | PubMed |
| Role of the Sympathetic Nervous System in Mild Chronic Inflammatory Diseases: Focus on Osteoarthritis. | Neuroimmunomodulation | 2023 | 37429263 | PubTator, text mining | PubMed |
| Renal injury, biomarkers, and myositis, an understudied aspect of disease: prospective study in the MyoCite cohort. | Front Med (Lausanne) | 2023 | 37425322 | PubTator, text mining | PubMed |
| A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways. | Prostate Int | 2023 | 37409095 | PubTator, text mining | PubMed |
| Aminoacyl-tRNA Synthetase-based Prognosis Model and Exploration of Potential Mechanisms in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 37408809 | PubTator, text mining | PubMed |
| NEAT1/microRNA 339-5p/SPI1 Axis Feedback Loop Contributes to Osteogenic Differentiation in Acute Suppurative Osteomyelitis in Children. | J Inflamm Res | 2023 | 37408606 | PubTator, text mining | PubMed |
| 10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection. | Breast | 2023 | 37393644 | PubTator, text mining | PubMed |
| Clinical and bi-genomic DNA findings of patients suspected to have mitochondrial diseases. | Front Genet | 2023 | 37377599 | PubTator, text mining | PubMed |
| Update on Classic and Novel Approaches in Metastatic Triple-Negative Breast Cancer Treatment: A Comprehensive Review. | Biomedicines | 2023 | 37371867 | PubTator, text mining | PubMed |
| Probenecid, an Old Drug with Potential New Uses for Central Nervous System Disorders and Neuroinflammation. | Biomedicines | 2023 | 37371611 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6012/papers?page=16